Mealey's (October 17, 2019, 12:51 PM EDT) -- ST. LOUIS — Johnson & Johnson kicked off a wide-reaching challenge to a $4.69 billion asbestos-talc ovarian cancer verdict by calling joint trial of 22 women’s claims covering 32 years of alleged exposure “patently irrational” in its Sept. 6 opening brief to a Missouri appeals court (Gail Ingham, et al. v. Johnson & Johnson, et al., No. ED 107476, Mo. App., Eastern Dist.)....